Literature DB >> 31482584

Neuroprotective effects of clavulanic acid following permanent bilateral common carotid artery occlusion in rats.

Mustafa Ghanbarabadi1, Farahnaz Falanji1, Abolfazl Rad2, Nafiseh Chazani Sharahi1, Sakineh Amoueian3, Mohamadreza Amin4, Mehdi Molavi5, Bahareh Amin6.   

Abstract

We investigated whether clavulanic acid could improve learning and memory, in rats underwent bilateral occlusion of common carotid artery (2VO). Seventy male Wistar rats were subjected to 2VO, with a 1-week interval between right and left artery occlusions. After 2VO, animals received clavulanic acid (10, 20, 40 mg/kg, intraperitoneally), from day 8 to 20. Spatial memory was assessed in the Morris water maze, 1 week after the induction of 2VO (day 15). The mRNA expression levels of bcl-2, bcl2-associated x protein (bax), caspase-3, inducible nitric oxide synthase (iNOS), and amyloid beta precursor protein (APP) were measured in the neocortex and hippocampus. Clavulanic acid significantly decreased the escape latency and swimming time in the training trial days. As well, it increased time and distance percentage in the target quadrant, while it decreased such factors in the opposite quadrant in the final trial day, compared to 2VO + normal saline animals. Real time-PCR data showed a significant higher mRNA expression of bax, caspase 3, and iNOS in the hippocampus and neocortex of 2VO animal compared to nonoccluded rats. APP increased in the neocortex but not hippocampus. Compared with 2VO animals, clavulanic acid significantly down-regulated the expression of iNOS, caspase 3, and APP, accompanied by diminishing the bax/bcl2 ratio. Our results reveal a potential therapeutic use of clavulanic acid for cognitive dysfunction associated with cerebral hypoperfusion in vascular dementia and Alzheimer disease.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; amyloid precursor protein; apoptosis; clavulanic acid; common carotid artery occlusion; nitrosative stress

Mesh:

Substances:

Year:  2019        PMID: 31482584     DOI: 10.1002/ddr.21595

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  2 in total

1.  Protective Effects of Chlorogenic Acid on Cerebral Ischemia/Reperfusion Injury Rats by Regulating Oxidative Stress-Related Nrf2 Pathway.

Authors:  Dequan Liu; Huilin Wang; Yangang Zhang; Zhan Zhang
Journal:  Drug Des Devel Ther       Date:  2020-01-07       Impact factor: 4.162

2.  Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer's Disease.

Authors:  Mahdieh Anoush; Zeinab Pourmansouri; Rafi Javadi; Benyamin GhorbanPour; Ali Sharafi; Hamed Mohamadpour; Iraj Jafari Anarkooli; Sina Andalib
Journal:  ACS Omega       Date:  2022-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.